Malignant mesothelioma therapeutic options and role of SV40: An update

Malignant Mesothelioma Therapeutic Options and Role of SV40: An Update

April 1, 2001

Date/Time: April 20-21, 2001
8:00 am-5:00 pm (Friday);
8:00 am-4:00 pm (Saturday)

The University of Chicago Gleacher Center
450 North Cityfront Plaza Drive
Chicago, IL 60611
Registration-6th Floor

Participants: Co-Chairmen:
Michele Carbone , MD, PhD-Loyola University Chicago
Nicholas J. Vogelzang, MD-University of Chicago Cancer Research Center

Plus more than 60 international faculty who are experts in lung cancer and mesothelioma,--including two Nobel Prize Winners.

This meeting will focus on the recent studies demonstrating that simian virus 40 (SV40) is associated with a significant portion of human mesotheliomas as well as brain and bone tumors. This conference will review current understanding of the role of SV40 in the pathogenesis of human mesothelioma, bone tumors, and brain tumors. The audience will include scientists from around the world, pharmaceutical supporters, and attorneys interested in the possible consequences of these studies. Asbestos build up was formerly considered one of the sole causes of mesothelioma.

A press briefing will take place on Saturday, April 21, 2001, at the Gleacher Center from 1:30 pm-2:30 pm. Press is invited to attend all meeting functions at no cost. Seating is limited.